TransAct Technologies (NASDAQ:TACT – Get Rating) had its price objective lowered by equities research analysts at Barrington Research from $20.00 to $15.00 in a research note issued to investors on Thursday, The Fly reports. Barrington Research’s target price points to a potential upside of 90.11% from the company’s current price.
Several other equities research analysts have also weighed in on TACT. Roth Capital decreased their price objective on TransAct Technologies from $21.00 to $14.00 in a report on Thursday. Craig Hallum reduced their target price on TransAct Technologies from $20.00 to $12.00 in a report on Thursday. Finally, StockNews.com assumed coverage on TransAct Technologies in a report on Thursday. They set a “hold” rating for the company. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $13.67.
Shares of NASDAQ TACT traded down $0.30 during mid-day trading on Thursday, reaching $7.89. 206 shares of the company’s stock were exchanged, compared to its average volume of 18,772. The firm has a market capitalization of $70.94 million, a price-to-earnings ratio of -12.73 and a beta of 1.98. TransAct Technologies has a 52 week low of $8.00 and a 52 week high of $17.18. The firm has a 50-day moving average price of $9.51 and a two-hundred day moving average price of $11.64.
TransAct Technologies (NASDAQ:TACT – Get Rating) last announced its quarterly earnings data on Wednesday, March 9th. The technology company reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.03. TransAct Technologies had a negative return on equity of 24.05% and a negative net margin of 14.79%. During the same period last year, the company posted ($0.22) earnings per share. On average, analysts expect that TransAct Technologies will post -0.83 earnings per share for the current fiscal year.
In other TransAct Technologies news, major shareholder 325 Capital Llc purchased 7,622 shares of the company’s stock in a transaction dated Thursday, January 27th. The stock was purchased at an average price of $8.66 per share, for a total transaction of $66,006.52. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 11.99% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of TACT. Barclays PLC lifted its position in TransAct Technologies by 238.0% in the 3rd quarter. Barclays PLC now owns 2,552 shares of the technology company’s stock worth $35,000 after buying an additional 1,797 shares during the last quarter. Manatuck Hill Partners LLC bought a new stake in TransAct Technologies in the 3rd quarter worth approximately $209,000. Morgan Stanley lifted its position in TransAct Technologies by 6.6% in the 2nd quarter. Morgan Stanley now owns 18,266 shares of the technology company’s stock worth $251,000 after buying an additional 1,134 shares during the last quarter. Potomac Capital Management Inc. bought a new stake in TransAct Technologies in the 4th quarter worth approximately $448,000. Finally, Mesirow Financial Investment Management Inc. bought a new stake in TransAct Technologies in the 3rd quarter worth approximately $455,000. Hedge funds and other institutional investors own 68.41% of the company’s stock.
TransAct Technologies Company Profile
TransAct Technologies, Inc operates as a software-driven technology and printing solutions company. It engages in food safety, POS automation, casino and gaming, lottery, mobile and oil and gas. The firm’s products are sold under the AccuDate, EPICENTRAL, Epic, Ithaca, RESPONDER and Printrex brands. It supplies consumables used in the printing and scanning activities of customers in the hospitality, banking, retail, gaming, government and oil and gas exploration markets.